Literature DB >> 9194222

Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity.

S V Peña1, A M Krensky.   

Abstract

A primary process by which cytotoxic T lymphocytes (CTL) and natural killer (NK) cells lyse target cells involves the regulated exocytosis of granules present in the cytoplasm of the effector. These granules contain proteins, such as perforin and the granzymes, that play a direct role in the killing process. The localization of a human T and NK cell-specific protein, granulysin (formerly 519), to cytolytic granules suggests that additional mechanisms may be involved in granule-mediated cytolysis. This protein shares homology with small, granule-associated molecules and is a member of a larger family of proteins known as saposin-like proteins (SAPLIP). SAPLIP share common structural features allowing for association with lipids while retaining the ability to mediate a variety of different functions. Expression of granulysin is induced late after T-cell activation, similar to perforin and the granzymes. Two prominent protein products of 15 and 9kDa were identified in CTL. The 9kDa form localizes to dense, highly cytolytic granules and contains the SAPLIP homology domain. A recombinant granulysin protein, corresponding to the 9kDa form, is cytolytic against tumor cell targets.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194222     DOI: 10.1006/smim.1997.0061

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  33 in total

1.  Expression and function of synaptotagmin VII in CTLs.

Authors:  Kimberly T Fowler; Norma W Andrews; James W Huleatt
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

2.  Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin.

Authors:  Qing Li; Chen Dong; Anmei Deng; Masao Katsumata; Ari Nakadai; Tomoyuki Kawada; Satoshi Okada; Carol Clayberger; Alan M Krensky
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa.

Authors:  Michael T Borchers; Nathaniel L Harris; Scott C Wesselkamper; Shiping Zhang; Yi Chen; Lisa Young; Gee W Lau
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Cholesterol in negatively charged lipid bilayers modulates the effect of the antimicrobial protein granulysin.

Authors:  Hanna Barman; Michael Walch; Sonja Latinovic-Golic; Claudia Dumrese; Max Dolder; Peter Groscurth; Urs Ziegler
Journal:  J Membr Biol       Date:  2007-01-06       Impact factor: 1.843

Review 5.  A short guided tour through functional and structural features of saposin-like proteins.

Authors:  Heike Bruhn
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

6.  Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy.

Authors:  Diana Di Liberto; Simona Buccheri; Nadia Caccamo; Serena Meraviglia; Amelia Romano; Paola Di Carlo; Lucina Titone; Francesco Dieli; Alan M Krensky; Alfredo Salerno
Journal:  Tuberculosis (Edinb)       Date:  2007-03-26       Impact factor: 3.131

7.  Expression of granulysin in polymyositis and inclusion-body myositis.

Authors:  K Ikezoe; S Ohshima; M Osoegawa; M Tanaka; K Ogawa; K Nagata; J-i Kira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10       Impact factor: 10.154

8.  Natural-killer cell-derived cytolytic molecules in HIV-associated pulmonary tuberculosis-role of exogenous interleukins.

Authors:  P V Ramana Rao; S Ramanavelan; S Rajasekaran; Alamelu Raja
Journal:  J Clin Immunol       Date:  2010-03-13       Impact factor: 8.317

9.  Increased granulysin expression in peripheral blood cells of patients with primary biliary cirrhosis and its clinical implications.

Authors:  Cheng Qian; Sunxiao Chen; Dingkang Yao; Chuanyong Wu; Tingwang Jiang; Jinshan Ke; Ye Zhou; Mingli Gu; Bo Chen; Anmei Deng; Renqian Zhong
Journal:  J Clin Immunol       Date:  2008-06-28       Impact factor: 8.317

10.  Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans.

Authors:  Heiko Bruns; Christoph Meinken; Philipp Schauenberg; Georg Härter; Peter Kern; Robert L Modlin; Christian Antoni; Steffen Stenger
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.